Overview Request Sample Pages Request Customization Download PDF
You are viewing: Australia Companion Animal Diagnostic Market analysis

The Australia Companion Animal Diagnostic Market was valued at $26.2 Million in 2026 and projected to reach to $40.4 Million by 2031, representing a compound annual growth rate of 9.1%. Australia's companion animal diagnostic market is positioned for sustained growth through 2031, supported by demographic shifts toward pet ownership and increased consumer awareness of animal health.

Australia Companion Animal Diagnostic Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Australia Companion Animal Diagnostic Market Trends and Insights

  • This 9.1% compound annual growth rate reflects increasing pet ownership, rising consumer spending on animal healthcare, and growing adoption of advanced diagnostic technologies across Australian veterinary clinics.
  • Australia's market is driven by heightened awareness of preventive care and the demand for rapid, accurate diagnostic solutions in companion animal medicine. The Australian companion animal diagnostic sector benefits from a mature veterinary infrastructure and strong regulatory frameworks that support innovation.
  • Between 2026 and 2031, Australia is expected to see accelerated investment in point-of-care testing, imaging diagnostics, and laboratory automation.
  • Australia's growing middle-class pet owners and premium pet care spending patterns position the country as a key growth market within the Asia Pacific region, with diagnostic services becoming integral to routine veterinary practice..

Key Market Statistics

  • CAGR (2026-2031) 9.1% CAGR
  • Market Size, 2026 ~USD 26.2 Million
  • Forecast, 2031 ~USD 40.4 Million
  • Country Australia

Australia Companion Animal Diagnostic Market Overview

Strong Market Growth :

Australia's companion animal diagnostic market is expanding at 9.1% CAGR, outpacing the global rate of 8.7%, driven by increasing pet ownership and elevated consumer spending on veterinary care.

Technology Adoption :

Australian veterinary clinics are rapidly adopting advanced diagnostic technologies including digital imaging, laboratory automation, and point-of-care testing systems to enhance service delivery.

Pet Ownership Trends :

Rising pet ownership rates across Australia, coupled with growing willingness to invest in preventive and diagnostic healthcare, are key drivers of market expansion through 2031.

Market Valuation :

The Australian market is valued at USD 26.2 million in 2026 and is forecast to reach USD 40.4 million by 2031, representing a 54% increase over the five-year period.

Australia Companion Animal Diagnostic Market Dynamics

  • The 9.1% CAGR reflects strong demand for diagnostic services across urban and regional veterinary practices.
  • Investment in modern diagnostic equipment and digital health solutions is accelerating, with Australian veterinarians increasingly adopting technologies that improve diagnostic accuracy and operational efficiency.
  • The market benefits from a developed healthcare infrastructure and high disposable incomes among pet owners willing to invest in comprehensive animal care.
  • Regulatory support for veterinary standards and growing collaboration between diagnostic providers and veterinary clinics further strengthen market dynamics..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • Australia's companion animal diagnostic market will grow from USD 26.2M (2026) to USD 40.4M (2031) at a 9.1% CAGR.
    • Australia's mature veterinary infrastructure and regulatory environment support rapid adoption of advanced diagnostic technologies.
    • Rising pet ownership and premium pet care spending in Australia drive demand for preventive diagnostic services.
    • Australia's market is positioned as a high-growth segment within Asia Pacific, driven by consumer awareness and veterinary innovation.

    Companion Animal Diagnostic Market Report Scope

    Report Metric Details
    Base Year 2026
    Fastest Growing Segment MOLECULAR DIAGNOSTICS (Technology)
    Forecast Period 2026–2031
    Growth Rate CAGR of 8.7% from 2026 to 2031
    Largest Segment CONSUMABLES (Product)
    Market Size Base Year (Billions) ~USD 3.56 (2026)
    Revenue Forecast (Billions) ~USD 5.4 (2031)
    Segments Covered Product, Technology, Type, Application, Animal Type, End User

    Australia Companion Animal Diagnostic Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Consumables
    • Instruments

    By Technology

    • Clinical Biochemistry
    • Hematology
    • Immunodiagnostics
    • Molecular Diagnostics
    • Other Technologies
    • Urinalysis

    By Type

    • Allergen-Specific Immunodiagnostic Tests
    • Blood Gas & Electrolyte Analysis
    • Blood Gas & Electrolyte Analyzers
    • Blood Gas & Electrolyte Reagents, Clips, And Cartridges
    • Blood Glucose Strips
    • Clinical Chemistry Analysis
    • Clinical Chemistry Analyzers
    • Clinical Chemistry Reagents, Clips, And Cartridges
    • Elisa Tests
    • Glucose Monitoring
    • Glucose Monitors
    • Hematology Analyzers
    • Hematology Cartridges
    • Immunoassay Analyzers
    • Lateral Flow Assays
    • Microarrays
    • Nucleic Acid Sequencing
    • Other Immunodiagnostics Products
    • Other Molecular Diagnostics Products
    • Pcr Tests
    • Radioimmunoassays
    • Rapid Tests
    • Strip Readers
    • Urinalysis Clips & Cartridges
    • Urine Analyzers
    • Urine Glucose Strips
    • Urine Test Strips

    By Application

    • Bacteriology
    • Clinical Pathology
    • Other Applications
    • Parasitology
    • Virology

    By Animal Type

    • Cats
    • Dogs
    • Horses
    • Other Companion Animals

    By End User

    • Home Care Settings
    • Veterinary Hospital & Clinics
    • Veterinary Reference Laboratories
    • Veterinary Research Institutes & Universities

    AUSTRALIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024–2031

    Segment20242025202620272028202920302031CAGR (%)
    HOME CARE SETTINGS2.42.733.43.84.34.85.412.6
    VETERINARY HOSPITAL & CLINICS19.220.622.324.326.428.831.434.39
    VETERINARY REFERENCE LABORATORIES88.79.610.511.612.814.115.610.3
    VETERINARY RESEARCH INSTITUTES & UNIVERSITIES2.12.32.42.62.833.33.68
    TOTAL31.734.237.340.844.648.953.658.99.6

    Target Audience

    • Veterinary Diagnostic Providers : Diagnostic equipment manufacturers and service providers need Australia-specific market data to identify expansion opportunities, assess competitive positioning, and develop localized product strategies.
    • Veterinary Clinic Operators : Clinic owners and managers require insights into diagnostic technology trends and market growth to make informed capital investment decisions and enhance service offerings in Australia.
    • Investment & Private Equity Firms : Investors evaluating opportunities in Australian veterinary healthcare need detailed market sizing, growth projections, and competitive analysis to assess portfolio potential and ROI.
    • Healthcare & Pharmaceutical Companies : Companies expanding into companion animal healthcare require Australia-specific market intelligence to understand demand drivers, regulatory requirements, and partnership opportunities.
    • Market Research & Consulting Professionals : Analysts and consultants need granular Australia market data to support client advisory work, competitive benchmarking, and strategic recommendations in the veterinary diagnostics sector.

    Key Companies in the Australia Companion Animal Diagnostic Market

    CompanyHQOwnershipStrongest segments
    MINDRAY MEDICAL INTERNATIONAL LIMITEDChinaPrivate CompanyPatient Monitoring and Life Support Products,In-Vitro Diagnostic Products,Medical Imaging Systems,
    QIAGEN NVNetherlandsPublic CompanySample technology consumables and instruments,Immune response and infectious disease diagnostics (incl. TB IGRA, transplant, viral load),Oncology, sexual and reproductive health assays,
    IDEXX LABORATORIES, INC.United StatesPublic CompanyCompanion Animal Group – in-clinic analyzers and SNAP rapid assays,Companion Animal Group – reference laboratories and telemedicine/consulting,Veterinary software, services, VetConnect PLUS and VetLab Station,
    FUJIFILM CORPORATIONJapanPublic CompanyHealthcare (medical devices, CDMO, pharma, regenerative medicine, cosmetics/supplements),Business Innovation (office equipment, document solutions, graphic communications, inkjet),Electronics (display, semiconductor materials, storage, industrial equipment, fine chemicals),
    THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLife Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
    BIOMéRIEUXFrancePublic CompanyClinical microbiology (culture media, VITEK 2, VITEK MS, AST including ETEST/VITEK REVEAL),Syndromic and molecular diagnostics (BIOFIRE, BIOFIRE SPOTFIRE, ARGENE, EMAG/NUCLISENS),Immunoassays and CLIA (VIDAS, Hybiome),
    BIONOTESouth KoreaPublic CompanyVeterinary fluorescence immunoassay and molecular diagnostics,Veterinary clinical biochemistry systems and reagents,Veterinary rapid immunoassay and ELISA kits,
    VIRBACFrancePublic CompanyCompanion-animal parasiticides and anti-infectives,Companion-animal specialty therapeutics & behavior (CKD diets, pheromones, mobility),Farm-animal vaccines (swine focus: Suigen range),

    MINDRAY MEDICAL INTERNATIONAL LIMITED

    Mindray Medical International Limited is a Chinese medical device manufacturer founded in 1991 with 8,400 employees. Operating as a private company, it specializes in diagnostic and monitoring equipment for healthcare applications.

    QIAGEN NV

    QIAGEN NV is a Dutch public company founded in 1984 with 5,500 employees. It provides molecular diagnostics, sample preparation, and life sciences research tools globally.

    IDEXX LABORATORIES, INC.

    IDEXX Laboratories, Inc. is a United States-based public company founded in 1983 with 11,000 employees. The company develops and manufactures diagnostic equipment and software for veterinary and water testing markets.

    FUJIFILM CORPORATION

    Fujifilm Corporation is a Japanese public company founded in 1934 with 73,526 employees. It operates across imaging, diagnostics, pharmaceuticals, and industrial products globally.

    THERMO FISHER SCIENTIFIC INC.

    Thermo Fisher Scientific Inc. is a United States public company founded in 1956 with 125,000 employees. It is a leading provider of laboratory equipment, reagents, and analytical instruments worldwide.

    BIOMéRIEUX

    bioMérieux is a French public company founded in 1963 with 14,894 employees. It specializes in in vitro diagnostics and microbiology testing solutions for clinical and industrial applications.

    BIONOTE

    BioNote is a South Korean public company founded in 2003 with 298 employees. The company develops and manufactures diagnostic devices and reagents for veterinary and clinical use.

    VIRBAC

    Virbac is a French public company founded in 1968 with 6,442 employees. It specializes in veterinary pharmaceuticals and animal health products.

    Reasons to Buy this Report

    • Market Size & Growth Data : Access precise valuation figures for Australia's companion animal diagnostic market with verified 2026-2031 forecasts, enabling accurate business planning and investment decisions.
    • Competitive Landscape Intelligence : Understand market dynamics specific to Australia, including technology adoption rates, key service providers, and competitive positioning within the regional veterinary diagnostic sector.
    • Regional Expansion Strategy : Identify growth opportunities across Australian urban and regional markets, with insights into pet ownership patterns, consumer spending behavior, and veterinary clinic distribution.
    • Technology & Innovation Trends : Discover which diagnostic technologies are gaining traction in Australian veterinary practices, including adoption rates for digital imaging, laboratory automation, and point-of-care solutions.
    • Strategic Investment Guidance : Make informed decisions on market entry, partnerships, or acquisitions in Australia with comprehensive data on market drivers, regulatory environment, and growth catalysts through 2031.

    Frequently asked questions

    What is the current size of Australia's companion animal diagnostic market?

    Australia's companion animal diagnostic market is valued at USD 26.2 million in 2026 and is projected to reach USD 40.4 million by 2031.

    What is the growth rate for Australia's companion animal diagnostic market?

    Australia's companion animal diagnostic market is expected to grow at a compound annual growth rate (CAGR) of 9.1% from 2026 to 2031.

    What factors are driving growth in Australia's companion animal diagnostic market?

    Key drivers include increasing pet ownership, rising consumer spending on premium pet healthcare, growing adoption of advanced diagnostic technologies, and heightened awareness of preventive care among Australian pet owners.

    How does Australia's market compare to the broader Asia Pacific region?

    Australia represents a high-growth segment within Asia Pacific, supported by a mature veterinary infrastructure, strong regulatory frameworks, and affluent pet-owning demographics that prioritize advanced diagnostic services.

    What diagnostic technologies are gaining traction in Australia?

    Point-of-care testing, advanced imaging diagnostics, and laboratory automation solutions are experiencing accelerated adoption across Australian veterinary clinics between 2026 and 2031.

    RESEARCH METHODOLOGY

    This research study extensively utilized both primary and secondary sources. It involved analyzing various factors influencing the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and strategies employed by key players.

    Secondary Research

    This research study utilized a variety of comprehensive secondary sources, including directories, databases such as Bloomberg Business, Factiva, and Dun & Bradstreet, white papers, annual reports, company house documents, investor presentations, and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the companion animal diagnostics market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments pertaining to both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.

    Primary Research

    In the primary research process, we interviewed a range of sources from both the supply and demand sides to gather qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the companion animal diagnostics market. Primary sources from the demand side include R&D product development teams in animal health companies, veterinary clinicians, diagnostic laboratory managers, and procurement heads at veterinary reference laboratories.

    Companion Animal Diagnostic Market Size, and Share

    Note: C-level executives include CEOs, COOs, CTOs, and VPs. Other designations include sales, marketing, and product managers.
    Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The total size of the companion animal diagnostics market was determined through data triangulation across three approaches, as described below. After each approach, the weighted average of the three was calculated based on the level of assumptions used in each.

    Companion Animal Diagnostic Market Top Down and Bottom Up Approach

    Data Triangulation

    After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed as applicable to complete the overall market engineering process and obtain exact statistics for all segments and subsegments.

    Market Definition

    Companion animal diagnostics use plasma, serum, blood, urine, feces, and tissue samples to detect, monitor, and manage diseases and health conditions in dogs, cats, horses, and other household pets. The companion animal diagnostics market includes diagnostic instruments, test kits, reagents, and consumables used in veterinary clinics and laboratories, covering technologies such as clinical chemistry analyzers, hematology analyzers, immunodiagnostics and ELISA test kits, urinalysis systems, molecular diagnostic assays, glucose monitoring systems, and blood gas–electrolyte analyzers. These products support routine wellness screening, disease diagnosis, treatment monitoring, and preventive healthcare in companion animals.

    Key Stakeholders

    • Companion animal diagnostic manufacturers
    • Companion animal diagnostic distributors and suppliers
    • Companion animal R&D companies
    • Veterinary reference laboratories
    • Veterinary hospitals and clinics
    • Veterinary universities and research institutes
    • Government associations
    • Market research and consulting firms
    • Venture capitalists and investors
    • Distributors, channel partners, and third-party suppliers

    Report Objectives

    • To define, describe, segment, and forecast the companion animal diagnostics market by product, technology, application, animal type, end user, and region
    • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall companion animal diagnostics market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the companion animal diagnostics market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile the key players in the companion animal diagnostics market and comprehensively analyze their core competencies and market shares
    • To analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships

    Available customizations:

    Based on the given market data, MarketsandMarkets offers customization to meet your company’s specific needs. The following customization options are available for the report:

    Company Information
    • Detailed analysis and profiling of additional market players (up to 5)
    Geographic Analysis
    • Further breakdown of the Rest of European companion animal diagnostics market into Austria, Finland, Switzerland, and other countries
    • Further breakdown of the Rest of Latin American companion animal diagnostics market into Colombia, Chile, and other countries
    Competitive Landscape Assessment
    • Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the companion animal diagnostics market
    • Competitive leadership mapping for established players in the US

     

    Get the Full Companion Animal Diagnostic Market Report

    Full forecast, segment splits, and company analysis for all Companion Animal Diagnostic Market.

    Download Sample Pages Buy Report

    METHODOLOGY

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    Cite this Research
    DMCA.com Protection Status